OSR Health OSRH
OTC OSRH
$0.20 -0.02 (-9.09%)
At close: Sep 28, 2026 · 4:00 PM EDT

OSR Health (OSRH) EBITDA (2024 - 2026)

Updated

OSR Health (OSRH) posted EBITDA of -$669,973 for Q2 2026, compared with -$2.88 million a year earlier.

Analysis

OSR Health (OSRH) EBITDA (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at OSR Health was -$7.42 million; for FY2025, it came in at -$9.03 million.

  • In prior years, OSR Health's EBITDA was -$2 million in FY2024.
  • The Q2 2026 figure stands as the highest quarterly EBITDA since Q1 2025.
  • According to Business Quant data, EBITDA for the three prior quarters was -$1.24 million (Q1 2026), -$4.09 million (Q4 2025) and -$1.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 OSR Health 6.58 Mn 19.54 Mn 86,605.00 -669,973.17
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -669,973.17
Mar 31, 2026 -1.24 Mn
Dec 31, 2025 -4.09 Mn
Sep 30, 2025 -1.42 Mn
Jun 30, 2025 -2.88 Mn
Mar 31, 2025 -644,631.29
Dec 31, 2024 -459,387.00
Sep 30, 2024 -736,132.00
Jun 30, 2024 -417,286.00
Mar 31, 2024 -389,418.00
API Access

OSR Health EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=OSRH&period=max&api_key=YOUR_API_KEY